RECURRENT GLIOBLASTOMA
Clinical trials for RECURRENT GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug targets recurrent brain cancer in small early trial
Disease control TerminatedThis early-stage study tested a new drug called RMC-5552 in 7 adults whose glioblastoma (a type of brain cancer) had returned after standard treatment. The drug works by blocking a protein that helps cancer cells grow. The main goals were to find the safest dose and see if the dr…
Matched conditions: RECURRENT GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Nicholas Butowski • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
Experimental brain cancer drug shows promise in early trial
Disease control TerminatedThis early-stage trial tested the drug navtemadlin in 32 adults with glioblastoma, an aggressive brain cancer. The goal was to find the safest dose and see how much drug reaches the tumor. The study was stopped early, but results may guide future treatments.
Matched conditions: RECURRENT GLIOBLASTOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 00:29 UTC
-
Hormone therapy explored for aggressive brain tumor
Disease control TerminatedThis early-phase trial tested whether natural progesterone, a hormone, could help control tumor growth in patients with recurrent glioblastoma (a type of brain cancer). Only 4 patients were enrolled before the study was stopped. The goal was to find the right dose and check for s…
Matched conditions: RECURRENT GLIOBLASTOMA
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC